Connaughton Bernadette
Director
3 filings on record here, covering HALO, EDIT. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-11
| Sell | HALO | HALOZYME THERAPEUTICS, INC. | $167,153 |
CORPORATEFiled 2026-07-02
| Sell | HALO | HALOZYME THERAPEUTICS, INC. | $76,395 |
| Sell | HALO | HALOZYME THERAPEUTICS, INC. | $48,256 |
CORPORATEFiled 2026-06-22
| Award | EDIT | Editas Medicine, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.